Sign In
Buy STAA
$28.26
-0.230 (-0.81%)
At Close: Jun 03, 2026
STAA Investors Have Opportunity to Join STAAR Surgical Company Fraud Investigation with the Schall Law Firm
07:59pm, Wednesday, 12'th Feb 2025
LOS ANGELES--(BUSINESS WIRE)--The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of STAAR Surgical Company (“Staar�
The Schall Law Firm Invites Shareholders With Losses In STAAR Surgical Company To Join A Securities Fraud Investigation
07:15pm, Wednesday, 12'th Feb 2025
LOS ANGELES, CA / ACCESS Newswire / February 12, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of STAAR Su
STAAR Surgical Q4: Ongoing Challenges In China Masks Healthy Growth Elsewhere
10:10am, Wednesday, 12'th Feb 2025
STAAR Surgical's Q4 results were severely impacted by lower demand and high inventory levels in China. Global growth ex-China was 17% in Q4 and is expected to remain strong at 12% for FY25, with US gr
STAAR Surgical Reports Fourth Quarter and Fiscal Year 2024 Results
04:01pm, Tuesday, 11'th Feb 2025
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, t
STAAR Surgical: Growth Story Remains Intact Despite Some Challenges
10:38am, Friday, 31'st Jan 2025
Shares have been under pressure lately due to weak demand from China, which is by far the company's largest market. The market opportunity in the US remains large, and management is investing heavily
STAAR Surgical to Host Fourth Quarter and Fiscal Year 2024 Earnings Conference Call and Webcast on February 19, 2025
07:00am, Monday, 13'th Jan 2025
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, t
STAAR Surgical to Participate in BTIG Ophthalmology Day
07:00am, Monday, 25'th Nov 2024
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia,
A Dive into Staar Surgical (STAA) International Revenue Trends and Forecasts
10:22am, Monday, 04'th Nov 2024
Evaluate Staar Surgical's (STAA) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
STAAR Surgical Company (STAA) Q3 2024 Earnings Call Transcript
10:57pm, Wednesday, 30'th Oct 2024
STAAR Surgical Company (NASDAQ:STAA ) Q3 2024 Earnings Conference Call October 30, 2024 4:30 PM ET Company Participants Brian Moore - VP, IR Tom Frinzi - Chair, President and CEO Patrick Williams - CF
CORRECTING and REPLACING STAAR Surgical Reports Third Quarter 2024 Results
10:21pm, Wednesday, 30'th Oct 2024
LAKE FOREST, Calif.--(BUSINESS WIRE)--The end of the paragraph after bullets in the "Outlook" section of release should read: APAC sales growth of 5% (prior outlook was 7%), including approximately 2
Staar Surgical (STAA) Surpasses Q3 Earnings and Revenue Estimates
06:37pm, Wednesday, 30'th Oct 2024
Staar Surgical (STAA) came out with quarterly earnings of $0.41 per share, beating the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.30 per share a year ago.
STAAR Surgical Reports Third Quarter 2024 Results
04:01pm, Wednesday, 30'th Oct 2024
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia,
STAAR Surgical to Report Third Quarter Results on October 30, 2024
07:00am, Wednesday, 23'rd Oct 2024
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia,
Here's Why Staar Surgical (STAA) Could be Great Choice for a Bottom Fisher
10:56am, Monday, 07'th Oct 2024
Staar Surgical (STAA) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among
Fast Money traders share their favorite stocks of the week
06:28pm, Friday, 27'th Sep 2024
Fast Money traders Steve Grasso, Tim Seymour, Julie Biel, and Mike Khouw share their favorite stocks from this week and explain the reasoning behind their choices.
